Filing Flows › Sonoma Pharmaceuticals (SNOA) › Q1 FY27 › vs Q1 FY26
Sonoma Pharmaceuticals (SNOA) Q1 FY27 vs Q1 FY26 (year over year)
Sonoma Pharmaceuticals's revenue rose $2.4M (+60%) from $4.0M in Q1 FY26 to $6.4M in Q1 FY27.
Sonoma Pharmaceuticals, Q1 FY27: revenue $6.4M (+60% year over year), operating margin -0.6%, net loss $330K, operating cash flow −$649K. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $6.4M | $4.0M | $2.4M | +60% |
| Net loss | $330K | $1.2M | −$911K | -73% |
| Costs & expenses | $6.7M | $5.3M | $1.5M | +28% |
| Operating costs | $6.4M | $5.1M | $1.3M | +26% |
| Interest & other, net | $290K | $147K | $143K | +97% |
| Cost of revenue | $3.8M | $2.6M | $1.3M | +50% |
| Research & development | $597K | $594K | $3K | +0.5% |
| SG&A | $2.0M | $2.0M | $55K | +3% |
| Operating cash sources | $739K | $2.1M | −$1.4M | -65% |
| Depreciation & amortization | $32K | $36K | −$4K | -11% |
| Share-based compensation | $58K | $57K | $1K | +2% |
| Cash used in operations | $649K | $2.0M | −$1.4M | -68% |
| Net loss absorbed | $330K | $1.2M | −$911K | -73% |
| Working capital & other | $409K | $867K | −$458K | -53% |
Questions
How much did Sonoma Pharmaceuticals's revenue grow year over year in Q1 FY27?
Sonoma Pharmaceuticals's revenue rose $2.4M (+60%) from $4.0M in Q1 FY26 to $6.4M in Q1 FY27.